These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 1712512)

  • 1. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
    Messmore HL; Griffin B; Koza M; Seghatchian J; Fareed J; Coyne E
    Semin Thromb Hemost; 1991; 17 Suppl 1():57-9. PubMed ID: 1712512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets.
    Messmore HL; Griffin B; Fareed J; Coyne E; Seghatchian J
    Ann N Y Acad Sci; 1989; 556():217-32. PubMed ID: 2472085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin and heparinoids on platelet aggregation.
    Cepelák V; Roubal Z; Zemanová I; Opatrný K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets of patients with peripheral arterial disease demonstrate a hypersensitive response to heparin.
    Reininger CB; Greinacher A; Eibl-Eibesfeldt B; Lasser R; Steckmeier B; Schweiberer L
    Int Angiol; 1996 Sep; 15(3):207-14. PubMed ID: 8971577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of platelets with standard heparin and low molecular weight fractions.
    Dunn FW; Soria C; Thomaidis A; Soria J; Dupuy E; Bellucci S; Tobelem G
    Nouv Rev Fr Hematol (1978); 1984; 26(4):249-53. PubMed ID: 6089103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.
    Basic-Micic M; Breddin HK
    Semin Thromb Hemost; 1993; 19 Suppl 1():22-8. PubMed ID: 8395725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-associated thrombocytopenia: the antibody is not heparin specific.
    Greinacher A; Michels I; Mueller-Eckhardt C
    Thromb Haemost; 1992 May; 67(5):545-9. PubMed ID: 1325681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
    Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
    Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From unfractionated heparins to low molecular weight heparins.
    Hirsh J
    Acta Chir Scand Suppl; 1990; 556():42-50. PubMed ID: 1705072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
    Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
    Keeling DM; Richards EM; Baglin TP
    Br J Haematol; 1994 Feb; 86(2):425-6. PubMed ID: 7515270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
    Hoppensteadt DA; Walenga JM; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 1():60-4. PubMed ID: 2068572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
    Bendayan P; Boccalon H; Dupouy D; Boneu B
    Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin and platelets.
    Warkentin TE; Kelton JG
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):243-64. PubMed ID: 1690205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
    Nimmerfall K; Mischke R
    Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.